Overtesting of women on levothyroxine treatment during pregnancy

  • Jana Bartakova Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University in Prague,Prague, Czech Republic
  • Jan Kratky Third Department of Medicine,General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
  • Hana Vitkova Third Department of Medicine,General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
  • Zdenka Limanova Third Department of Medicine,General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
  • Kaleem Zia Khwaja Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University in Prague,Prague, Czech Republic
  • Jan Jiskra Third Department of Medicine,General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
Keywords: Thyroid Disorders, Pregnancy, Levothyroxine, Antibodies to Thyroid Peroxidase, Thyroid Stimulatory Hormone

Abstract

Laboratory check-up every four weeks during the first half of pregnancy and at least once in the 3rd trimester among pregnant women treated with levothyroxine is recommended by the guidelines of American Thyroid Association 2011.

References

Burrow GH. Thyroid status in normal pregnancy. The Journal of clinical endocrinology and metabolism. 1990;71(2):274-5.

Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocrine reviews. 1997;18(3):404-33.

Vaidya B, Anthony S, Bilous M, Shields B, Drury J, Hutchison S, et al. Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high-risk case finding? The Journal of clinical endocrinology and metabolism. 2007;92(1):203-7.

Springer D, Zima T, Limanova Z. Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. European journal of endocrinology / European Federation of Endocrine Societies. 2009;160(5):791-7.

Lazarus JH, Kokandi A. Thyroid disease in relation to pregnancy: a decade of change. Clinical endocrinology. 2000;53(3):265-78.

Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid : official journal of the American Thyroid Association. 2011;21(10):1081-125.

van Walraven C, Raymond M. Population-based study of repeat laboratory testing. Clinical chemistry. 2003;49(12):1997-2005.

Zamrazil V, Bilek R, Cerovska J, Delange

F. The elimination of iodine deficiency in the Czech Republic: the steps toward success. Thyroid : official journal of the American Thyroid Association. 2004;14(1):49-56.

Lazarus JH. Thyroid function in pregnancy. British medical bulletin. 2011;97:137-48.

Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocrine reviews. 2010;31(5):702-55.

Dosiou C, Barnes J, Schwartz A, Negro R, Crapo L, Stagnaro-Green A. Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women. The Journal of clinical endocrinology and metabolism. 2012;97(5):1536-46.

Lazarus JH. Screening for thyroid dysfunction in pregnancy: is it worthwhile? Journal of thyroid research. 2011;2011:397012.

Dave A, Maru L, Tripathi M. Importance of Universal screening for thyroid disorders in first trimester of pregnancy. Indian journal of endocrinology and metabolism. 2014;18(5):735-8.

Abalovich M, Alcaraz G, Kleiman-Rubinsztein J, Pavlove MM, Cornelio C, Levalle O, et al. The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism. Thyroid : official journal of the American Thyroid Association. 2010;20(10):1175-8.

Abalovich M, Vazquez A, Alcaraz G, Kitaigrodsky A, Szuman G, Calabrese C, et al. Adequate levothyroxine doses for the treatment of hypothyroidism newly discovered during pregnancy. Thyroid : official journal of the American Thyroid Association. 2013;23(11):1479-83.

Negro R, Stagnaro-Green A. Diagnosis and management of subclinical hypothyroidism in pregnancy. BMJ (Clinical research ed). 2014;349:g4929.

Lazarus J, Brown RS, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Vaidya B. 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. European thyroid journal. 2014;3(2):76-94.

Taylor PN, Minassian C, Rehman A, Iqbal A, Draman MS, Hamilton W, et al. TSH levels and risk of miscarriage in women on long-term levothyroxine: a community-based study. The Journal of clinical endocrinology and metabolism. 2014;99(10):3895-902.

Obregon MJ, Calvo RM, Del Rey FE, de Escobar GM. Ontogenesis of thyroid function and interactions with maternal function. Endocrine development. 2007;10:86-98.

Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. The New England journal of medicine. 2004;351(3):241-9.

Bartakova J, Potlukova E, Rogalewicz V, Fait T, Schondorfova D, Telicka Z, et al. Screening for autoimmune thyroid disorders after spontaneous abortion is cost-saving and it improves the subsequent pregnancy rate. BMC pregnancy and childbirth. 2013;13:217.
Published
2015-06-30
Section
Case Report